Contracts Finder · Award
Gene Technology
A public procurement published by BIRMINGHAM CHILDRENS HOSPITAL via Contracts Finder.
- £45.9k
- Award value
- —
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
SureSeq Myeloid - target enrichment and next gen sequencing system
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85000000 — Health and social work services
- Currency
- GBP
- Total award value
- £45,891
- Tender value
- —
- First published
- 15 Aug 2017
- Last updated
- 15 Aug 2017
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Oxford Gene Technology | 03043815 | 29 May 2017 | active | £45.9k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from BIRMINGHAM CHILDRENS HOSPITAL
FAQs about this procurement
Who is the buyer for "Gene Technology"?
Gene Technology is a UK public-sector procurement published by BIRMINGHAM CHILDRENS HOSPITAL via Contracts Finder.
Has "Gene Technology" been awarded?
Yes — 1 award is recorded, with a reported total value of £45,891. The current lifecycle stage is "Award".
Which suppliers are involved in "Gene Technology"?
1 supplier is linked: Oxford Gene Technology.
What is "Gene Technology" worth?
The reported award value is £45,891.
When was "Gene Technology" published?
It was first published on 15 Aug 2017 and last updated on 15 Aug 2017, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable